Celltrion Group Chairman Jung-Jin Seo lead aggressive movements for Remsima to U.S. market

An event to celebrate the U.S. launch of the Celltrion’s antibody biosimilar, Remsima(U.S. name: Inflectra) was held on the 5th of December(local time) in Las Vegas, USA.

In order to wish a successful launch of Remsima that was first introduced in the U.S. market, Celltrion Group Chairman Jung-Jin Seo participated in the ceremony.

At the event, according to Celltrion, Chairman Seo promised co...